TP53 and B-cell chronic lymphocytic leukemia: MinION has already been successfully used by our group to detect mutations of the TP53 and ABL1 genes in chronic lymphocytic leukemia (CLL) and in chronic myeloid leukemia (CML) patients, respectively [8,9,10].